Normally, antizyme serves as an anti-tumor regulatory agent by facilitating ubiquitin-independent degradation of several growth-promoting proteins including ornithine decarboxylase (ODC), cyclin D1, SMAD1, MSP1, Aurora A kinase and MYC [9]. The gene discussed is MYC; the disease is neoplasm.